Skip to content

DRMA

Dermata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.83
−3.31%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 18, 2026
EPS estimate
-$0.55
Revenue estimate
$25.0K

Latest reported

Last report date
Aug 11, 2026
EPS actual
-$0.74
EPS estimate
-$0.55
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
8
EPS in line (12Q)
0
Avg surprise (4Q)
-6.9%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 11, 2026-$0.55-$0.74Miss -34.55%—
May 13, 2026-$0.53-$0.48Beat 9.43%—
Mar 26, 2026-$1.54-$1.52Beat 1.30%—
Nov 14, 2025-$1.59-$1.65Miss -3.77%—
Aug 13, 2025-$2.90-$1.66Beat 42.76%—
Mar 17, 2025-$1.50-$3.15Miss -110.00%—
Nov 13, 2024-$2.64-$2.04Beat 22.73%—
May 15, 2024-$5.40-$7.05Miss -30.56%—
Mar 21, 2024-$0.78-$3.15Miss -303.85%—
Nov 9, 2023-$0.63-$8.10Miss -1185.71%—
Aug 10, 2023-$0.92-$9.45Miss -927.17%—
May 11, 2023-$2.65-$34Miss -1184.15%—

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026